{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-036357","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2022-12-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.897568+00:00","generated_at":"2026-06-21T00:08:45.826308+00:00","sec_items":["1.01","3.02","3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"INBS closes $220k private placement of Series D convertible preferred and warrants","bullets":["Gross proceeds of $220,585 from sale of 176,462 Series D convertible preferred shares and 529,386 warrants at $1.25/unit.","Each preferred share initially convertible into 3 common shares; warrants exercisable at $0.29/share for 5 years.","Conversion requires shareholder approval; preferred shares carry voting rights only on reverse stock split proposals.","Insider participation: CFO Spiro Sakiris ($19,991) and Director Manuel Kostandas ($13,327) purchased 26,655 units combined.","Proceeds to be used for general working capital; placement agent Winx Capital receives 6% fee and 26,469 warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-036357","json":"https://secwatch.observer/filing/0001493152-22-036357.json","markdown":"https://secwatch.observer/filing/0001493152-22-036357.md","text":"https://secwatch.observer/filing/0001493152-22-036357.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315222036357/0001493152-22-036357-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315222036357/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T00:08:45.826308+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cc521b3e0f864549d3ce18a6745db0ab9e6752a6","claim":"INTELLIGENT BIO SOLUTIONS INC. entered into Purchase Agreement with 14 investors valued at $220,585 (effective 2022-12-21).","evidence_excerpt":"On December 21, 2022, Intelligent Bio Solutions Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with 14 investors (the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors in a Regulation S private placement (the “Transaction”) (i) 176,462 shares of the Company’s Series D Convertible Preferred Stock (the “Preferred Stock”), par value $0.01 per share (the “Preferred Stock”), and (ii) 529,386 warrants (the “Warrants”), with each Warrant representing the right to purchase one share of the Company’s common stock (“Common Stock”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315222036357/0001493152-22-036357-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"14 investors"},{"label":"Value","value":"$220,585"},{"label":"Effective","value":"2022-12-21"}],"fact_type":"material_agreement"},{"claim_id":"fd03f3e8c0d5023bf9e6615fba08730f4e0323b5","claim":"INTELLIGENT BIO SOLUTIONS INC. entered into Engagement Letter with Winx Capital Pty Ltd. (effective 2022-12-16).","evidence_excerpt":"On December 16, 2022, the Company entered into Engagement Letter (the “Engagement Letter”) with Winx Capital Pty Ltd. ( CAR for AFSL (Australian Financial Services License) #330757) (“Winx Capital”) pursuant to which Winx Capital agreed to serve as a consultant acting as placement agent on a best efforts basis in connection with the private placement of the Units in the Transaction.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315222036357/0001493152-22-036357-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Winx Capital Pty Ltd."},{"label":"Effective","value":"2022-12-16"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}